Target Gene/Pathway(薬物標的遺伝子/パスウェイリスト)💬 Info on mouse-over

52 / 286 pathways

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Acute myeloid leukemia 💬
1件: KIT 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
2 Acute myeloid leukemia 💬
1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
3 AMPK signaling pathway 💬
1件: HMGCR 💬 D00887 💬 Atorvastatin 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬
4 AMPK signaling pathway 💬
1件: HMGCR 💬 D07474 💬 Atorvastatin 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬
5 Axon guidance 💬
1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
6 Axon guidance 💬
1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
7 Bile secretion 💬
1件: HMGCR 💬 D00887 💬 Atorvastatin 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬
8 Bile secretion 💬
1件: HMGCR 💬 D07474 💬 Atorvastatin 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬
9 Biosynthesis of cofactors 💬
2件: NQO1, VKORC1 💬 D00564 💬 Warfarin 11件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬
10 Biosynthesis of cofactors 💬
2件: NQO1, VKORC1 💬 D01280 💬 Warfarin 11件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬
11 Biosynthesis of cofactors 💬
2件: NQO1, VKORC1 💬 D08682 💬 Warfarin 11件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬
12 Breast cancer 💬
1件: KIT 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
13 Breast cancer 💬
1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
14 Calcium signaling pathway 💬
1件: EDNRA 💬 D07077 💬 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211 💬
15 Calcium signaling pathway 💬
2件: EDNRA, EDNRB 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
16 Calcium signaling pathway 💬
2件: EDNRA, EDNRB 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
17 Calcium signaling pathway 💬
2件: EDNRA, EDNRB 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
18 Calcium signaling pathway 💬
1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
19 Calcium signaling pathway 💬
1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
20 cAMP signaling pathway 💬
1件: EDNRA 💬 D07077 💬 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211 💬
21 cAMP signaling pathway 💬
1件: EDNRA 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
22 cAMP signaling pathway 💬
1件: EDNRA 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
23 cAMP signaling pathway 💬
1件: EDNRA 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
24 Cell cycle 💬
1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
25 Cell cycle 💬
1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
26 Central carbon metabolism in cancer 💬
2件: KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
27 Central carbon metabolism in cancer 💬
2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
28 cGMP-PKG signaling pathway 💬
1件: EDNRA 💬 D07077 💬 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211 💬
29 cGMP-PKG signaling pathway 💬
2件: EDNRA, EDNRB 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
30 cGMP-PKG signaling pathway 💬
2件: EDNRA, EDNRB 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
31 cGMP-PKG signaling pathway 💬
2件: EDNRA, EDNRB 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
32 cGMP-PKG signaling pathway 💬
3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 D09572 💬 Riociguat 6件: 51, 84, 86, 88, 225, 299 💬
33 Choline metabolism in cancer 💬
1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
34 Choline metabolism in cancer 💬
1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
35 Chronic myeloid leukemia 💬
1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
36 Chronic myeloid leukemia 💬
1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
37 Circadian entrainment 💬
3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 D09572 💬 Riociguat 6件: 51, 84, 86, 88, 225, 299 💬
38 Complement and coagulation cascades 💬
1件: F10 💬 D09710 💬 Edoxaban 2件: 46, 88 💬
39 EGFR tyrosine kinase inhibitor resistance 💬
1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
40 EGFR tyrosine kinase inhibitor resistance 💬
1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
41 Endocytosis 💬
1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
42 Endocytosis 💬
1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
43 ErbB signaling pathway 💬
1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
44 ErbB signaling pathway 💬
1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
45 Fluid shear stress and atherosclerosis 💬
1件: NQO1 💬 D00564 💬 Warfarin 11件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬
46 Fluid shear stress and atherosclerosis 💬
1件: NQO1 💬 D01280 💬 Warfarin 11件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬
47 Fluid shear stress and atherosclerosis 💬
1件: NQO1 💬 D08682 💬 Warfarin 11件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬
48 Focal adhesion 💬
1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
49 Focal adhesion 💬
1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
50 Gap junction 💬
3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 D09572 💬 Riociguat 6件: 51, 84, 86, 88, 225, 299 💬
51 Gap junction 💬
1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
52 Gap junction 💬
1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
53 Glioma 💬
1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
54 Glioma 💬
1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
55 Hematopoietic cell lineage 💬
1件: KIT 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
56 Hematopoietic cell lineage 💬
1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
57 Hepatocellular carcinoma 💬
1件: NQO1 💬 D00564 💬 Warfarin 11件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬
58 Hepatocellular carcinoma 💬
1件: NQO1 💬 D01280 💬 Warfarin 11件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬
59 Hepatocellular carcinoma 💬
1件: NQO1 💬 D08682 💬 Warfarin 11件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬
60 Human cytomegalovirus infection 💬
1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
61 Human cytomegalovirus infection 💬
1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
62 JAK-STAT signaling pathway 💬
1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
63 JAK-STAT signaling pathway 💬
1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
64 Long-term depression 💬
3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 D09572 💬 Riociguat 6件: 51, 84, 86, 88, 225, 299 💬
65 MAPK signaling pathway 💬
2件: KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
66 MAPK signaling pathway 💬
2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
67 Melanogenesis 💬
1件: EDNRB 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
68 Melanogenesis 💬
1件: EDNRB 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
69 Melanogenesis 💬
1件: EDNRB 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
70 Melanogenesis 💬
1件: KIT 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
71 Melanogenesis 💬
1件: KIT 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
72 Melanoma 💬
1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
73 Melanoma 💬
1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
74 Metabolic pathways 💬
3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 D09572 💬 Riociguat 6件: 51, 84, 86, 88, 225, 299 💬
75 Metabolic pathways 💬
1件: HMGCR 💬 D00887 💬 Atorvastatin 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬
76 Metabolic pathways 💬
1件: HMGCR 💬 D07474 💬 Atorvastatin 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬
77 Metabolic pathways 💬
2件: NQO1, VKORC1 💬 D00564 💬 Warfarin 11件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬
78 Metabolic pathways 💬
2件: NQO1, VKORC1 💬 D01280 💬 Warfarin 11件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬
79 Metabolic pathways 💬
2件: NQO1, VKORC1 💬 D08682 💬 Warfarin 11件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬
80 MicroRNAs in cancer 💬
2件: ABL1, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
81 MicroRNAs in cancer 💬
2件: ABL1, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
82 Neuroactive ligand-receptor interaction 💬
1件: EDNRA 💬 D07077 💬 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211 💬
83 Neuroactive ligand-receptor interaction 💬
2件: EDNRA, EDNRB 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
84 Neuroactive ligand-receptor interaction 💬
2件: EDNRA, EDNRB 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
85 Neuroactive ligand-receptor interaction 💬
2件: EDNRA, EDNRB 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
86 Neuroactive ligand-receptor interaction 💬
1件: PTGIR 💬 D09994 💬 Selexipag 5件: 51, 70, 84, 86, 88 💬
87 Neuroactive ligand-receptor interaction 💬
1件: PTGIR 💬 D06213 💬 Treprostinil 6件: 51, 84, 85, 86, 88, 210 💬
88 Neurotrophin signaling pathway 💬
1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
89 Neurotrophin signaling pathway 💬
1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
90 Oxytocin signaling pathway 💬
3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 D09572 💬 Riociguat 6件: 51, 84, 86, 88, 225, 299 💬
91 Pathogenic Escherichia coli infection 💬
1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
92 Pathogenic Escherichia coli infection 💬
1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
93 Pathways in cancer 💬
3件: ABL1, KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
94 Pathways in cancer 💬
3件: ABL1, KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
95 Pathways in cancer 💬
1件: EDNRA 💬 D07077 💬 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211 💬
96 Pathways in cancer 💬
2件: EDNRA, EDNRB 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
97 Pathways in cancer 💬
2件: EDNRA, EDNRB 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
98 Pathways in cancer 💬
2件: EDNRA, EDNRB 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
99 Pathways in cancer 💬
1件: NQO1 💬 D00564 💬 Warfarin 11件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬
100 Pathways in cancer 💬
1件: NQO1 💬 D01280 💬 Warfarin 11件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬
101 Pathways in cancer 💬
1件: NQO1 💬 D08682 💬 Warfarin 11件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬
102 Phospholipase D signaling pathway 💬
2件: KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
103 Phospholipase D signaling pathway 💬
2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
104 PI3K-Akt signaling pathway 💬
2件: KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
105 PI3K-Akt signaling pathway 💬
2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
106 Platelet activation 💬
3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 D09572 💬 Riociguat 6件: 51, 84, 86, 88, 225, 299 💬
107 Platelet activation 💬
1件: PTGIR 💬 D09994 💬 Selexipag 5件: 51, 70, 84, 86, 88 💬
108 Platelet activation 💬
1件: PTGIR 💬 D06213 💬 Treprostinil 6件: 51, 84, 85, 86, 88, 210 💬
109 Prostate cancer 💬
1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
110 Prostate cancer 💬
1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
111 Purine metabolism 💬
3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 D09572 💬 Riociguat 6件: 51, 84, 86, 88, 225, 299 💬
112 Rap1 signaling pathway 💬
2件: KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
113 Rap1 signaling pathway 💬
2件: KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
114 Ras signaling pathway 💬
3件: ABL1, KIT, PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
115 Ras signaling pathway 💬
3件: ABL1, KIT, PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
116 Regulation of actin cytoskeleton 💬
1件: PDGFRA 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
117 Regulation of actin cytoskeleton 💬
1件: PDGFRA 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
118 Relaxin signaling pathway 💬
1件: EDNRB 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
119 Relaxin signaling pathway 💬
1件: EDNRB 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
120 Relaxin signaling pathway 💬
1件: EDNRB 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
121 Renin secretion 💬
1件: EDNRA 💬 D07077 💬 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211 💬
122 Renin secretion 💬
1件: EDNRA 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
123 Renin secretion 💬
1件: EDNRA 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
124 Renin secretion 💬
1件: EDNRA 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
125 Renin secretion 💬
3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 D09572 💬 Riociguat 6件: 51, 84, 86, 88, 225, 299 💬
126 Salivary secretion 💬
3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 D09572 💬 Riociguat 6件: 51, 84, 86, 88, 225, 299 💬
127 Terpenoid backbone biosynthesis 💬
1件: HMGCR 💬 D00887 💬 Atorvastatin 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬
128 Terpenoid backbone biosynthesis 💬
1件: HMGCR 💬 D07474 💬 Atorvastatin 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬
129 Ubiquinone and other terpenoid-quinone biosynthesis 💬
2件: NQO1, VKORC1 💬 D00564 💬 Warfarin 11件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬
130 Ubiquinone and other terpenoid-quinone biosynthesis 💬
2件: NQO1, VKORC1 💬 D01280 💬 Warfarin 11件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬
131 Ubiquinone and other terpenoid-quinone biosynthesis 💬
2件: NQO1, VKORC1 💬 D08682 💬 Warfarin 11件:  6 ,  8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬
132 Vascular smooth muscle contraction 💬
1件: EDNRA 💬 D07077 💬 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211 💬
133 Vascular smooth muscle contraction 💬
1件: EDNRA 💬 D01227 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
134 Vascular smooth muscle contraction 💬
1件: EDNRA 💬 D07538 💬 Bosentan 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
135 Vascular smooth muscle contraction 💬
1件: EDNRA 💬 D10135 💬 Macitentan 5件: 51, 85, 86, 88, 210 💬
136 Vascular smooth muscle contraction 💬
3件: GUCY1A1, GUCY1A2, GUCY1B1 💬 D09572 💬 Riociguat 6件: 51, 84, 86, 88, 225, 299 💬
137 Vascular smooth muscle contraction 💬
1件: PTGIR 💬 D09994 💬 Selexipag 5件: 51, 70, 84, 86, 88 💬
138 Vascular smooth muscle contraction 💬
1件: PTGIR 💬 D06213 💬 Treprostinil 6件: 51, 84, 85, 86, 88, 210 💬
139 Viral myocarditis 💬
1件: ABL1 💬 D01441 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
140 Viral myocarditis 💬
1件: ABL1 💬 D08066 💬 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬